The Global Medical Cannabis Market Review examines the status and dynamics of the international medical cannabis supply chain, highlighting emerging developments and trends in key international markets.
Published by Prohibition Partners, the report provides country-specific data and analysis, comparing countries based on relevant metrics including volumes of exports and imports, market size, domestic production, product and distribution landscape.
Prohibition Partners was founded in 2017 with a vision for a legal cannabis industry where the abundant economic, societal and health benefits of the plant can be realised by people around the world. This report includes market sizing and patient population forecasts for 14 key international markets – from 2026-2030. Also included is graphical and narrative analysis of the market size and the driving forces behind growth. In addition, scenario forecasting for Australia & Germany will also be included.
The Review delves deeper into the driving forces behind international import and supply chain dynamics, as well as factors such as: domestic production capabilities in various countries, the impact of telemedicine on patient access and care, and recent regulatory changes that shape the landscape of medical cannabis. By analysing these elements, the Review aims to offer insights into market growth potential and the evolving global context of medical cannabis supply and demand.
For more information about this report, including a 45-page free download, visit:
https://prohibitionpartners.com/reports/global-medical-cannabis-market-review-2026/